Rivaroxaban Orally Disintegrating Film Composition, and Preparation Method and Use Thereof

TW202633651APending Publication Date: 2026-08-16SHANGHAI BOCIMED PHARMA CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114134945
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-09-03
Filing Date
2025-09-11
Publication Date
2026-08-16
Patent Text Reader

Abstract

The present invention provides a rivaroxaban orally disintegrating film composition, a preparation method thereof and a use thereof. The rivaroxaban orally disintegrating film composition comprises an active drug and a film-forming material; the active drug is one or more of 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide represented by Formula I, pharmaceutically acceptable salts, hydrates and solvates thereof. The rivaroxaban orally disintegrating film composition provided by the present invention has the advantages of good taste, stable properties, high dissolution rate, immediate dissolution in the oral cavity without drinking water, no gritty feeling after dissolution in the oral cavity, and fast oral absorption rate. Meanwhile, the present invention has simple process, no sedimentation during the preparation of film liquid, content uniformity meeting requirements, high drug loading, improved clinical patient compliance, is particularly suitable for patients with dysphagia, and has good marketization prospect.
Need to check novelty before this filing date? Find Prior Art